Although the present study provided solid experimental basis (in vitro in cell model and in vivo in mice model) for understanding the role of Sfrp1 inhibiting Wnt/β-catenin signaling pathway activity in acute myocardial infarction, there are more investigations should be finished before clinical trial. The gene discussed is SFRP1; the disease is myocardial infarction.